腎臓内科
腎臓内科業績
1. Uchiyama Y, Ohashi N, Iwakura T, Isobe S, Fujikura T, Fujigaki Y, Shimizu A, Yasuda H. An atypical case of proliferative glomerulonephritis with monoclonal Immunoglobulin G1 κ deposits with organized structural deposits. CEN Case Rep. 2025 Dec 22;15(1):2.
2. Matsuyama T, Yamawaki M, Furuya J, Omata K, Kaneko M, Furuya R, Yasuda H, Fukasawa H. Serum Uric Acid as a Potential Risk Marker for Atherosclerotic Cardiovascular Disease in Japanese Adults: Using the Hisayama Study-based Prediction Model. JMA J. 2025 Oct 15;8(4):1116-1123.
3. Ema C, Iwakura T, Tsuji N, Nakayama Y, Tsuchida M, Kitamura A, Katahashi N, Ishigaki S, Isobe S, Fujikura T, Ohashi N, Kato A, Sugimoto K, Yasuda H. Teneligliptin and empagliflozin attenuate ferroptosis-mediated acute tubular injury. Nephrol Dial Transplant. 2025 Oct 3:gfaf203.
4. Aoki T, Ohashi N, Uchiyama Y, Matsuyama T, Ishigaki S, Isobe S, Ishibashi M, Iwakura T, Fujikura T, Kato A, Sugimoto K, Yasuda H. Sodium appetite is enhanced in 5/6 nephrectomized rat by high-sodium diet via increased levels of angiotensin II in the subfornical organ. Hypertens Res. 2025 Oct;48(10):2595-2605.
5. Fujikura T, Isobe S, Oikawa S, Ishigaki S, Katahashi N, Iwakura T, Ohashi N, Kato A, Yasuda H. Comparison of seroconversion rates after hepatitis B vaccination in patients with advanced chronic kidney disease and those receiving maintenance hemodialysis. Clin Exp Nephrol. 2025 Aug;29(8):1045-1052.
6. Fukasawa H, Yamawaki M, Furuya J, Omata K, Kaneko M, Matsuyama T, Yasuda H, Furuya R. The effects of zinc supplementation on body fat mass in hemodialysis patients: An open-label randomized controlled trial. Ther Apher Dial. 2025 Apr;29(2):170-177.
7. Asai Y, Iwakura T, Ishigaki S, Isobe S, Fujikura T, Ohashi N, Kato A, Yasuda H. Diagnostic Pitfalls of the Bleeding Origin after a Percutaneous Renal Biopsy. Intern Med. 2025 Mar 15;64(6):881-885.
2. Matsuyama T, Yamawaki M, Furuya J, Omata K, Kaneko M, Furuya R, Yasuda H, Fukasawa H. Serum Uric Acid as a Potential Risk Marker for Atherosclerotic Cardiovascular Disease in Japanese Adults: Using the Hisayama Study-based Prediction Model. JMA J. 2025 Oct 15;8(4):1116-1123.
3. Ema C, Iwakura T, Tsuji N, Nakayama Y, Tsuchida M, Kitamura A, Katahashi N, Ishigaki S, Isobe S, Fujikura T, Ohashi N, Kato A, Sugimoto K, Yasuda H. Teneligliptin and empagliflozin attenuate ferroptosis-mediated acute tubular injury. Nephrol Dial Transplant. 2025 Oct 3:gfaf203.
4. Aoki T, Ohashi N, Uchiyama Y, Matsuyama T, Ishigaki S, Isobe S, Ishibashi M, Iwakura T, Fujikura T, Kato A, Sugimoto K, Yasuda H. Sodium appetite is enhanced in 5/6 nephrectomized rat by high-sodium diet via increased levels of angiotensin II in the subfornical organ. Hypertens Res. 2025 Oct;48(10):2595-2605.
5. Fujikura T, Isobe S, Oikawa S, Ishigaki S, Katahashi N, Iwakura T, Ohashi N, Kato A, Yasuda H. Comparison of seroconversion rates after hepatitis B vaccination in patients with advanced chronic kidney disease and those receiving maintenance hemodialysis. Clin Exp Nephrol. 2025 Aug;29(8):1045-1052.
6. Fukasawa H, Yamawaki M, Furuya J, Omata K, Kaneko M, Matsuyama T, Yasuda H, Furuya R. The effects of zinc supplementation on body fat mass in hemodialysis patients: An open-label randomized controlled trial. Ther Apher Dial. 2025 Apr;29(2):170-177.
7. Asai Y, Iwakura T, Ishigaki S, Isobe S, Fujikura T, Ohashi N, Kato A, Yasuda H. Diagnostic Pitfalls of the Bleeding Origin after a Percutaneous Renal Biopsy. Intern Med. 2025 Mar 15;64(6):881-885.